Solid Biosciences Rises as Investors Focus on Rare-Disease Pipeline
Solid Biosciences Inc. shares drew fresh focus Friday as the biotech’s gene therapy pipeline kept the stock active. Shares closed at $7.24 Thursday, up about 6%. H.C. Wainwright had raised its price target two days earlier. Trading ranged between $6.87 and $7.50, with volume at about 1.01 million, market data showed. Timing counts here. Nasdaq’s main hours are 9:30 a.m. to 4:00 p.m. Eastern, and the trading day hadn’t started yet at the dateline. Premarket trading is the early window before the bell, and often sees thin volume, so small trades can swing prices more than later in the day.